SCHEMBL8375852

SCHEMBL8375852

CPN1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823805 0.89
SCHEMBL22826724 0.83
SCHEMBL13210464 0.72
SCHEMBL10073158 0.67
SCHEMBL6472299 0.67
SCHEMBL21276591 0.65 RAB9A (0.34)
SCHEMBL20344714 0.64 MGLL (0.33)
Hydrochloric Acid SCHEMBL29213084 0.64
SCHEMBL8660421 0.62
SCHEMBL11108320 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3360858-B1 PROCESS FOR PRODUCING AN AMINOPYRROLIDINE DERIVATIVE MITSUBISHI TANABE PHARMA CORP (JP) 2020-04-29 EP disclosed
CN-107569518-A The dissolving method of the egg shell membrane of enzyme is used 天野酶制品株式会社 2018-01-12 CN disclosed
CN-105671018-A Eggshell membrane solubilization method using enzymes 天野酶制品株式会社 2016-06-15 CN disclosed
CN-103069000-A Method for dissolving eggshell membrane using enzyme AMANO ENZYME INC 2013-04-24 CN disclosed
US-7812158-B2 Coupling agents for peptide synthesis UNIVERSITY OF MASSACHUSETTS (US) 2010-10-12 US disclosed
US-20070112196-A1 New coupling agents for peptide synthesis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-05-17 US disclosed
EP-0901500-A1 $i(IN SITU) PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE IN SYNTHESIS OF OLIGONUCLEOTIDES HYBRIDON, Inc. (US) 1999-03-17 EP disclosed
WO-1997042208-A1 IN SITU PREPARATION OF NUCLEOSIDE PHOSPHORAMIDITES AND THEIR USE IN SYNTHESIS OF OLIGONUCLEOTIDES HYBRIDON, INC. (US) 1997-11-13 WO disclosed